New treatment option shows promise for severe hypertrophic cardiomyopathy in children
Graphical abstract. Credit: JACC: Basic to Translational Science (2024). DOI: 10.1016/j.jacbts.2024.10.002 Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality...
Read moreDetails